Drug companies say enough U.S. states join $26 bln opioid settlement to proceed


Article content

Three large U.S. drug distributors and the drugmaker Johnson & Johnson will move forward with a proposed $26 billion settlement resolving claims that they fueled the opioid epidemic after “enough” states joined the deal, according to letters on Saturday reviewed by Reuters. (Reporting by Nate Raymond in Boston Editing by Matthew Lewis and Sonya Hepinstall)